Physitrack
13.10.2021 08:21:38 CEST | ACCESS Newswire | Press release
LONDON, GB / ACCESSWIRE / October 13, 2021 / Physitrack (STO:PTRK)
The B2B SaaS and Virtual Care provider Physitrack PLC plans to publish its Q3 interim report 2020/2021 on Wednesday October 20, at 8.00 CET. A webcast conference will take place at 10.00 CET.
Physitrack PLC's Q3 interim report 2020/2021 will be published in English and available on https://www.physitrackgroup.com/investors/reports-presentations.
Webcast conference:
October 20, 2021 at 10.00 CET. The presentation will be held in English and will be available on https://www.physitrackgroup.com/investors/reports-presentations after the webcast conference.
Speakers:
Henrik Molin, CEO
Charlotte Goodwin, CFO
Link to webcast:
https://tv.streamfabriken.com/physitrack-group-q3-2021
Dial-in number for teleconference:
SE: +46856642695
UK: +443333009268
US: +16467224956
For further information, please contact:
Investor contact: Kristian Stålberg, +46 (0) 720 18 05 93, ir@physitrack.com
Media contact: Kristian Stålberg, +46 (0) 720 18 05 93, media@physitrack.com
About Physitrack PLC
Physitrack Plc, founded in 2012, is a global digital healthcare provider, mainly focused on the B2B physiotherapy and musculoskeletal care market. With staff on four continents, customers in 17 time zones, and patients in 187 countries, Physitrack is a truly global company.
The company has two business lines:
1. Software-as-a-Service (SaaS)-based software platform tailored to physiotherapy and musculoskeletal care, encompassing clinical home exercises, education prescription, outcomes tracking, triaging and Telehealth.
2. Virtual-first wellness and care provision powered by the Physitrack technology platform and care professionals based in the United Kingdom.
Physitrack Plc is headquartered in London, United Kingdom, and listed on Nasdaq First North Premier Growth Market (PTRK).
FNCA Sweden AB is appointed Certified Adviser, info@fnca.se, +46 (0) 8 528 00 399
For further information, please visit https://www.physitrackgroup.com/
SOURCE: Physitrack
View source version on accesswire.com:
https://www.accesswire.com/667867/Invitation-to-Physitrack-PLC-Q3-Interim-Report-20202021-Webcast-Conference
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
LiberNovo 2026 Triple Launch: SE, Pro, and Maxis Introduce Dynamic Ergonomics for Every Body Type Across Europe18.5.2026 19:00:00 CEST | Press release
LONDON, GB / ACCESS Newswire / May 18, 2026 / LiberNovo, the premium ergonomic chair brand pioneering movement-based seating, today confirmed the full details of its 2026 product expansion for the European market. Three new lines-the Omni SE, Omni Pro, and the all-new Maxis series-will be available to customers across the UK and EU starting June 16, with pre-orders now open. Across Europe, the shift toward hybrid and remote work has turned the home office into a permanent fixture. Yet the chair at the centre of that setup is often the last thing to be upgraded. Most ergonomic seating still operates on a decades-old premise: find the correct posture, lock it in, stay put. LiberNovo rejects that model entirely. Its Dynamic Ergonomics platform is built around continuous adaptation-chairs that respond to how users actually move through their day, rather than forcing them into a fixed position. With three distinct product lines, that approach now reaches users of every build and budget. Omn
Europe's Healthcare IT Market Enters the 2027 Readiness Cycle as Black Book Names 26 Top Client-Rated Vendors During HIMSS26 Week in Copenhagen18.5.2026 18:00:00 CEST | Press release
Category-specific honors identify client-rated leaders in data-ready EHRs, interoperability, enterprise imaging, cloud, cybersecurity, AI, advisory, analytics, clinical decision support and digital health infrastructure COPENHAGEN, DK / ACCESS Newswire / May 18, 2026 / Black Book Research today announced its 2026 European Healthcare IT Client Satisfaction Honors, recognizing 26 healthcare technology vendors and platforms whose strongest client-facing performance aligns with the next phase of European digital health: trusted data, cross-border interoperability, AI accountability, cybersecurity resilience, cloud modernization, enterprise imaging liquidity, analytics readiness and clinical workflow transformation. The announcement is timed to HIMSS26 Europe, taking place 19-21 May 2026 at the Bella Center in Copenhagen, Denmark, where healthcare leaders, innovators and policymakers are convening around digital maturity, AI, interoperability, cybersecurity and health system transformation.
Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization18.5.2026 14:37:00 CEST | Press release
Forbes' Third Highest-Paid Athlete in the World Brings Global Platform to Datavault AI's Sports Illustrated Exchange and NIL Monetization Initiative PHILADELPHIA, PA / ACCESS Newswire / May 18, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset (‘RWA') tokenization technologies, today announced that two-time world heavyweight champion Tyson Fury has signed on as International Spokesperson for Datavault AI a deal brokered by Nick Hunter of P11. Ranked No. 3 on Forbes' 2025 list of the world's highest-paid athletes with $146 million in estimated earnings (Forbes 2025), Fury brings global star power, and a uniquely personal understanding of what it means to own, protect, and capitalize on a name, to Datavault AI's mission of empowering individuals and organizations to monetize their data and digital assets. Known worldwide as "The Gypsy King," his appointment immediately precede
Tabor Redefines Anti-Drone Testing with Software-Defined SDR Platform15.5.2026 22:55:00 CEST | Press release
NESHER, ISRAEL / ACCESS Newswire / May 15, 2026 / Tabor Electronics today announced the commercial release of its Anti-Drone Test and Evaluation (T&E) solution, introducing a software-defined approach to validating counter-unmanned aircraft systems (C-UAS). Built on the company's Proteus™ Software Defined Radio (SDR) platform, the solution enables defense and security organizations to test and deploy counter-drone technologies in rapidly changing threat environments. As low-cost drones proliferate and communication protocols evolve, traditional hardware-bound test environments are struggling to keep pace. Tabor's platform replaces these constraints with a programmable framework that allows engineering teams to emulate and validate real-world RF scenarios in controlled lab environments-reducing reliance on extended field testing while accelerating development timelines. Originally developed in collaboration with leading anti-drone technology companies, the solution has already been prov
Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program14.5.2026 21:05:00 CEST | Press release
Highlights: WellCare Today brings established RPM, RTM and CCM infrastructure with wearable technology integrations and connected monitoring solutions Combination expected to integrate Wellgistics Health recently announced MSO initiative with Kare Clinicals and its network of 6,500+ independent pharmacies Proposed platform designed to enhance patient engagement, medication adherence, remote monitoring and longitudinal care coordination Proposed transaction valued at approximately $15 million Strategic initiative intended to create additional clinical revenue opportunities for participating pharmacies and providers TAMPA, FL / ACCESS Newswire / May 14, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced that it has executed a non-binding letter of intent ("LOI") to acquire WellCare Today. The proposed transaction structure includes a structured cash payment of $3 million,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom